medtech

medtech

Source: Sensydia

More than six million U.S. adults are currently living with heart failure. By 2030, that number is expected to climb to nearly 8 million.

Currently, the way to test for heart failure is a painstaking process known as cardiac catheterization.

Simply put, the procedure involves inserting a tiny tube into a blood vessel in someone’s arm or leg and injecting a dye that’s visible to an X-ray. Pressure and flow of blood in the heart are measured, and the photos taken via X-ray show where the heart or arteries are damaged or blocked. Hazards of the process include strokes or heart attacks, tearing arterial lining or blood clots.

Read moreShow less
Evan Xie

Agoura Hills-based clinical biopharmaceutical company Acelyrin went public on the NASDAQ markets May 5, securing one of Los Angeles’ most valuable initial public offerings in two years.

The IPO priced Acelyrin’s 34.5 million shares at $18 apiece, netting the company $621 million. It is now trading under the symbol SLRN.

Read moreShow less
Photo: GigXR

Santa Monica-based GigXR is aiming to meld mixed reality with real life to create the most immersive training experience for medics that don’t otherwise have reliable access to cadavers.

GigXR was founded by David King Lassman in 2019 to build realistic mixed-reality simulations. According to CEO Jared Mermey who was previously an angel investor and joined the company in February 2022, using a mixed-reality learning module allows for “basically unlimited repetition,” and added, “there’s no marginal cost to using software.”

It’s an interesting proposal, particularly for members of the armed forces. Mock surgeries, Mermey said, often are time-consuming to set up and break down. Not to mention that there’s long been a shortage of cadavers to learn from. To that end, Mermey envisions a time where combat medic training is as simple as putting on a headset or picking up a smartphone.

Read moreShow less
Trending